Jeffrey Burdick

1.1k total citations
16 papers, 850 citations indexed

About

Jeffrey Burdick is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Jeffrey Burdick has authored 16 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Jeffrey Burdick's work include Cardiac Fibrosis and Remodeling (3 papers), Signaling Pathways in Disease (3 papers) and Additive Manufacturing and 3D Printing Technologies (3 papers). Jeffrey Burdick is often cited by papers focused on Cardiac Fibrosis and Remodeling (3 papers), Signaling Pathways in Disease (3 papers) and Additive Manufacturing and 3D Printing Technologies (3 papers). Jeffrey Burdick collaborates with scholars based in United States and United Kingdom. Jeffrey Burdick's co-authors include Vasant Jayasankar, Y. Joseph Woo, Timothy J. Pirolli, Timothy J. Gardner, Lawrence T. Bish, Mark F. Berry, H. Lee Sweeney, Kevin Morine, Mark F. Berry and Daniel Henkel and has published in prestigious journals such as Circulation, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

In The Last Decade

Jeffrey Burdick

16 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Burdick United States 12 366 223 216 205 124 16 850
Helen Greutert Switzerland 13 174 0.5× 109 0.5× 195 0.9× 235 1.1× 25 0.2× 21 771
M.A. Bowes United Kingdom 24 691 1.9× 166 0.7× 53 0.2× 212 1.0× 158 1.3× 81 1.8k
Huajian Teng China 23 282 0.8× 92 0.4× 48 0.2× 562 2.7× 32 0.3× 56 1.6k
Yue Zhu China 18 307 0.8× 195 0.9× 16 0.1× 385 1.9× 23 0.2× 42 1.1k
Alain van Mil Netherlands 21 300 0.8× 22 0.1× 242 1.1× 1.1k 5.5× 58 0.5× 42 1.7k
P. A. Doevendans Netherlands 13 294 0.8× 24 0.1× 388 1.8× 513 2.5× 32 0.3× 26 1.2k
Qiming Duan United States 18 78 0.2× 16 0.1× 117 0.5× 580 2.8× 29 0.2× 31 946
Shuguang Liu China 20 228 0.6× 19 0.1× 281 1.3× 795 3.9× 126 1.0× 90 1.5k
Ao Chen China 17 176 0.5× 72 0.3× 292 1.4× 462 2.3× 36 0.3× 54 1.1k
Yizhong Peng China 18 205 0.6× 207 0.9× 80 0.4× 311 1.5× 21 0.2× 47 943

Countries citing papers authored by Jeffrey Burdick

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Burdick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Burdick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Burdick more than expected).

Fields of papers citing papers by Jeffrey Burdick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Burdick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Burdick. The network helps show where Jeffrey Burdick may publish in the future.

Co-authorship network of co-authors of Jeffrey Burdick

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Burdick. A scholar is included among the top collaborators of Jeffrey Burdick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Burdick. Jeffrey Burdick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Burdick, Jeffrey, et al.. (2019). Infrared-assisted acoustic emission process monitoring for additive manufacturing. AIP conference proceedings. 2102. 20006–20006. 18 indexed citations
3.
Croom, Brendan P., et al.. (2018). Revealing mechanisms of residual stress development in additive manufacturing via digital image correlation. Additive manufacturing. 22. 1–12. 103 indexed citations
4.
Burdick, Jeffrey, Brian R. Berridge, & Robert W. Coatney. (2015). Strain echocardiography combined with pharmacological stress test for early detection of anthracycline induced cardiomyopathy. Journal of Pharmacological and Toxicological Methods. 73. 15–20. 9 indexed citations
5.
Jayasankar, Vasant, Y. Joseph Woo, Timothy J. Pirolli, et al.. (2005). Induction of Angiogenesis and Inhibition of Apoptosis by Hepatocyte Growth Factor Effectively Treats Postischemic Heart Failure. Journal of Cardiac Surgery. 20(1). 93–101. 66 indexed citations
6.
Woo, Y. Joseph, Todd Grand, Mark F. Berry, et al.. (2005). Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery. 130(2). 321–329. 40 indexed citations
7.
Jayasankar, Vasant, Lawrence T. Bish, Timothy J. Pirolli, et al.. (2004). Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function. The Annals of Thoracic Surgery. 77(6). 2122–2129. 17 indexed citations
8.
Jayasankar, Vasant, Timothy J. Pirolli, Lawrence T. Bish, et al.. (2004). Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy. Journal of Molecular and Cellular Cardiology. 36(4). 531–538. 15 indexed citations
9.
Woo, Y. Joseph, Matthew Taylor, Jeffrey Е. Cohen, et al.. (2004). Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. Journal of Thoracic and Cardiovascular Surgery. 127(5). 1262–1269. 80 indexed citations
10.
Berry, Mark F., Y. Joseph Woo, Timothy J. Pirolli, et al.. (2004). Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. The Journal of Heart and Lung Transplantation. 23(9). 1061–1068. 45 indexed citations
11.
Berry, Mark F., Timothy J. Pirolli, Lawrence T. Bish, et al.. (2004). TNF inhibition at the time of myocardial infarction attenuates the subsequent development of heart failure. The Journal of Heart and Lung Transplantation. 23(2). S174–S174. 1 indexed citations
12.
Jayasankar, Vasant, Y. Joseph Woo, Lawrence T. Bish, et al.. (2004). Inhibition of Matrix Metalloproteinase Activity by TIMP-1 Gene Transfer Effectively Treats Ischemic Cardiomyopathy. Circulation. 110(11_suppl_1). II180–6. 43 indexed citations
13.
Berry, Mark F., Timothy J. Pirolli, Vasant Jayasankar, et al.. (2004). Apelin Has In Vivo Inotropic Effects on Normal and Failing Hearts. Circulation. 110(11_suppl_1). II187–93. 232 indexed citations
14.
Friedberg, Joseph S., et al.. (2003). A novel technique for light delivery through branched or bent anatomic structures. Journal of Thoracic and Cardiovascular Surgery. 126(6). 1963–1967. 5 indexed citations
15.
Jayasankar, Vasant, Y. Joseph Woo, Lawrence T. Bish, et al.. (2003). Gene Transfer of Hepatocyte Growth Factor Attenuates Postinfarction Heart Failure. Circulation. 108(10_suppl_1). II230–6. 93 indexed citations
16.
Chatterjee, Subhasis, Allan Stewart, Lawrence T. Bish, et al.. (2002). Viral Gene Transfer of the Antiapoptotic Factor Bcl-2 Protects Against Chronic Postischemic Heart Failure. Circulation. 106(12_suppl_1). I212–7. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026